ArticleIET nanobiotechnology2021
Biosynthesis of reduced graphene oxide using Turbinaria ornata and its cytotoxic effect on MCF-7 cells.
Article in IET nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- Towards greener reduced graphene oxide: a critical review of environmentally driven reduction strategies.RSC advances · 2026Review
- Application of Laser-Induced Graphene Flexible Sensor in Monitoring Large Deformation of Reinforced Concrete Structure.Sensors (Basel, Switzerland) · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
Graphene-based nanomaterials are gaining importance in biomedicine because of their large surface areas, solubility, and biocompatibility. Green synthesis is the most economical method for application, as it is rapid and sustainable. Biofunctionalized reduced graphene oxide (TrGO) nanosheets were synthesized using methanol extract of Turbinaria ornata, and bioreduction of graphene oxide was primarily confirmed and characterized using UV-visible, Fourier transform infrared (FTIR), and X-ray diffraction spectroscopy and further characterized by zeta potential and transmission electron microscopy. The FTIR spectra of TrGO showed a decrease in the band intensities of oxygen groups, thus confirming effective deoxygenation. The zeta potential value of -34.6 mV revealed that synthesized TrGO was highly stable. The cytotoxic effect of TrGO against MCF-10A and MCF-7 cells was ascertained using MTT assay, showed a greater cytotoxic effect on MCF-7 cells. The IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.